Does Blue Shield of California cover Zepbound or Wegovy?
Last updated
It depends on the plan since 2026; some cover only at a BMI of 40.
If it is not covered: the lowest cash prices now

Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
It depends on the plan since 2026; some cover only at a BMI of 40. Blue Shield of California said from 1 January 2026 weight loss drug coverage varies by large group plan, may be limited to Class III obesity or BMI thresholds, and some employers offer none. In its words: "As of January 1, 2026, weight loss drug coverage will vary for Blue Shield large group commercial health plans. Depending on the member’s benefit plan, weight loss drug coverage for a member newly prescribed a weight loss drug may only be available for treatment of Class III obesity (BMI ≥ 40), or for BMI ≥ 30 or BMI ≥ 27 with certain conditions. Less commonly, employers may also choose not to offer any weight loss drug coverage." (Blue Shield of California provider news, 28 January 2026, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). From 1 January 2025 certain weight loss medications stopped being covered for some Blue Shield commercial PPO and HMO members unless authorized for Class III (morbid) obesity. In its words: "Beginning January 1, 2025, or upon the employer group’s or individual purchaser’s plan renewal after that date, certain weight loss medications will no longer be covered for some Blue Shield of California (Blue Shield) commercial PPO and HMO plan members unless authorization for medical necessity is provided by Blue Shield. Blue Shield will authorize weight loss medications for members affected by the benefit change if the medication is medically necessary for the treatment of a current or previous diagnosis of Class III (morbid) obesity." (Blue Shield of California provider news, 1 November 2024, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). From 1 July 2026 fully insured commercial HMO and PPO and select ASO members must move from the Zepbound auto-injector to the KwikPen. In its words: "Blue Shield of California has updated coverage requirements for Zepbound®, requiring fully insured commercial HMO and PPO and select ASO members to transition from the single-dose auto-injector to the multi-dose Zepbound KwikPen®, effective July 1, 2026. The KwikPen contains all four weekly doses in one pen per month supply and does not affect the medication’s safety or efficacy." (Blue Shield of California provider news, 29 April 2026, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026).
Blue Shield of California, Zepbound and Wegovy: common questions
Does Blue Shield of California cover Zepbound for weight loss?
It depends on the plan since 2026; some cover only at a BMI of 40. Blue Shield of California said from 1 January 2026 weight loss drug coverage varies by large group plan, may be limited to Class III obesity or BMI thresholds, and some employers offer none. In its words: "As of January 1, 2026, weight loss drug coverage will vary for Blue Shield large group commercial health plans. Depending on the member’s benefit plan, weight loss drug coverage for a member newly prescribed a weight loss drug may only be available for treatment of Class III obesity (BMI ≥ 40), or for BMI ≥ 30 or BMI ≥ 27 with certain conditions. Less commonly, employers may also choose not to offer any weight loss drug coverage." (Blue Shield of California provider news, 28 January 2026, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). From 1 January 2025 certain weight loss medications stopped being covered for some Blue Shield commercial PPO and HMO members unless authorized for Class III (morbid) obesity. In its words: "Beginning January 1, 2025, or upon the employer group’s or individual purchaser’s plan renewal after that date, certain weight loss medications will no longer be covered for some Blue Shield of California (Blue Shield) commercial PPO and HMO plan members unless authorization for medical necessity is provided by Blue Shield. Blue Shield will authorize weight loss medications for members affected by the benefit change if the medication is medically necessary for the treatment of a current or previous diagnosis of Class III (morbid) obesity." (Blue Shield of California provider news, 1 November 2024, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). From 1 July 2026 fully insured commercial HMO and PPO and select ASO members must move from the Zepbound auto-injector to the KwikPen. In its words: "Blue Shield of California has updated coverage requirements for Zepbound®, requiring fully insured commercial HMO and PPO and select ASO members to transition from the single-dose auto-injector to the multi-dose Zepbound KwikPen®, effective July 1, 2026. The KwikPen contains all four weekly doses in one pen per month supply and does not affect the medication’s safety or efficacy." (Blue Shield of California provider news, 29 April 2026, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). Zepbound not covered: the cash price at your dose
Does Blue Shield of California cover Wegovy for weight loss?
It depends on the plan since 2026; some cover only at a BMI of 40. Blue Shield of California said from 1 January 2026 weight loss drug coverage varies by large group plan, may be limited to Class III obesity or BMI thresholds, and some employers offer none. In its words: "As of January 1, 2026, weight loss drug coverage will vary for Blue Shield large group commercial health plans. Depending on the member’s benefit plan, weight loss drug coverage for a member newly prescribed a weight loss drug may only be available for treatment of Class III obesity (BMI ≥ 40), or for BMI ≥ 30 or BMI ≥ 27 with certain conditions. Less commonly, employers may also choose not to offer any weight loss drug coverage." (Blue Shield of California provider news, 28 January 2026, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). From 1 January 2025 certain weight loss medications stopped being covered for some Blue Shield commercial PPO and HMO members unless authorized for Class III (morbid) obesity. In its words: "Beginning January 1, 2025, or upon the employer group’s or individual purchaser’s plan renewal after that date, certain weight loss medications will no longer be covered for some Blue Shield of California (Blue Shield) commercial PPO and HMO plan members unless authorization for medical necessity is provided by Blue Shield. Blue Shield will authorize weight loss medications for members affected by the benefit change if the medication is medically necessary for the treatment of a current or previous diagnosis of Class III (morbid) obesity." (Blue Shield of California provider news, 1 November 2024, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). From 1 July 2026 fully insured commercial HMO and PPO and select ASO members must move from the Zepbound auto-injector to the KwikPen. In its words: "Blue Shield of California has updated coverage requirements for Zepbound®, requiring fully insured commercial HMO and PPO and select ASO members to transition from the single-dose auto-injector to the multi-dose Zepbound KwikPen®, effective July 1, 2026. The KwikPen contains all four weekly doses in one pen per month supply and does not affect the medication’s safety or efficacy." (Blue Shield of California provider news, 29 April 2026, blueshieldca.com/en/provider/news-education/news, read Nov 17, 2026). Wegovy not covered: the cash price at your dose
What do Zepbound and Wegovy cost if Blue Shield of California does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance
Does Medicaid cover Zepbound or Wegovy?
It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.